Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ABSTRACT


28 octubre 2015

THE LANCET. Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial

Dr Manel Sabaté, MD, Salvatore Brugaletta, MD, Angel Cequier, MD, Andrés Iñiguez, MD, Antonio Serra, MD, Pilar Jiménez-Quevedo, MD, Vicente Mainar, MD, Gianluca Campo, MD, Maurizio Tespili, MD, Peter den Heijer, MD, Armando Bethencourt, MD, Nicolás Vazquez, MD, Gerrit Anne van Es, PhD, Bianca Backx, RN, Marco Valgimigli, MD, Prof Patrick W Serruys, MD

Background: Data for the safety and efficacy of new-generation drug-eluting stents at long-term follow-up, and specifically in patients with ST-segment elevation myocardial infarction, are scarce. In the EXAMINATION trial, we compared everolimus-eluting stents (EES) with bare-metal stents (BMS) in an all-comer population with ST-segment elevation myocardial infarction. In this study, we assessed the 5-year outcomes of the population in the EXAMINATION trial.

29 octubre 2015

THE NEW ENGLAND JOURNAL OF MEDICINE. Paclitaxel-Eluting versus Everolimus-Eluting Coronary Stents in Diabetes

Upendra Kaul, M.D., Sripal Bangalore, M.D., M.H.A., Ashok Seth, M.D., Priyadarshini Arambam, M.Sc., Rajpal K. Abhaychand, M.D., Tejas M. Patel, M.D., Darshan Banker, M.D., Atul Abhyankar, M.D., Ajit S. Mullasari, M.D., Sanjay Shah, M.D., Rajneesh Jain, M.D., Premchand R. Kumar, M.D., and C.G. Bahuleyan, M.D. for the TUXEDO–India Investigators

BACKGROUND: The choice of drug-eluting stent in the treatment of patients with diabetes mellitus and coronary artery disease who are undergoing percutaneous coronary intervention (PCI) has been debated. Previous studies comparing paclitaxel-eluting stents with stents eluting rapamycin (now called sirolimus) or its analogues (everolimus or zotarolimus) have produced contradictory results, ranging from equivalence between stent types to superiority of everolimus-eluting stents.

01 julio 2015

EUROPEAN JOURNAL OF VASCULAR & ENDOVASCULAR SURGERY. Technical and Clinical Success and Long-Term Durability of Endovascular Treatment for Atherosclerotic Aortic Arch Branch Origin Obstruction: Evaluation of 144 Procedures

M.A.J. van de Weijer, E.J.P.A. Vonken, J.-P.P.M. de Vries, F.L. Moll, J.A. Vos, G.J. de Borst

Objectives: Endovascular treatment of atherosclerotic obstruction of aortic arch branch origins (AABO) has largely replaced open surgery, but long-term outcome data are lacking. This study evaluated mid-term and long-term results of these procedures.

01 julio 2015

EUROPEAN JOURNAL OF VASCULAR & ENDOVASCULAR SURGERY. Absolute Ethanol Embolization of Infiltrating-diffuse Extracranial Arteriovenous Malformations in the Head and Neck

L. Su, D. Wang, Y. Han, Z. Wang, L. Zheng, X. Fan

Objective: Extracranial arteriovenous malformations (AVMs) of an infiltrative type in the head and neck can cause cosmetic, functional, and psychological problems. This study reports a single center experience and evaluates the clinical safety and effectiveness of the sole use of absolute ethanol embolotherapy for infiltrative extracranial AVMs in the head and neck.

01 septiembre 2015

EUROPEAN JOURNAL OF VASCULAR & ENDOVASCULAR SURGERY. Mechanism of Procedural Stroke Following Carotid Endarterectomy or Carotid Artery Stenting Within the International Carotid Stenting Study (ICSS) Randomised Trial

A. Huibers, D. Calvet, F. Kennedy, K.R. Czuriga-Kovács, R.L. Featherstone, F.L. Moll, M.M. Brown, T. Richards, G.J. de Borst

Objective: To decrease the procedural risk of carotid revascularisation it is crucial to understand the mechanisms of procedural stroke. This study analysed the features of procedural strokes associated with carotid artery stenting (CAS) and carotid endarterectomy (CEA) within the International Carotid Stenting Study (ICSS) to identify the underlying pathophysiological mechanism.

01 septiembre 2015

EUROPEAN JOURNAL OF VASCULAR & ENDOVASCULAR SURGERY. Two Decades of Endovascular Repair of Popliteal Artery Aneurysm—A Meta-analysis

M. von Stumm, H. Teufelsbauer, H. Reichenspurner, E.S. Debus

Objective/Background: Over the last two decades endovascular repair (EVR) of popliteal artery aneurysms has emerged as a treatment alternative to conventional open surgical repair (OSR). The aim of this review was to evaluate the safety and efficiency of each repair method, comparing the following outcomes after EVR and OSR: (i) primary patency; (ii) operating time; (iii) length of hospital stay; (iv) peri-operative complications; (v) limb salvage; and (vi) patient survival.

01 noviembre 2015

EUROPEAN JOURNAL OF VASCULAR & ENDOVASCULAR SURGERY. Risk Factors Associated with Symptomatic Pulmonary Embolism of Catheter Directed Thrombolysis for Lower Extremity Deep Venous Thrombosis

F.H. Li, Y. Zhao, X.H. Wang, Q.N. Fu, H. Liu, W. Huang

Objective: The aim was to study the risk factors associated with symptomatic pulmonary embolism (PE) in patients with deep venous thrombosis (DVT) in the lower limbs treated by catheter directed thrombolysis (CDT) without inferior vena cava filter (IVCF) placement.

01 noviembre 2015

EUROPEAN JOURNAL OF VASCULAR & ENDOVASCULAR SURGERY. Same Site Recurrence is More Frequent After Endovenous Laser Ablation Compared with High Ligation and Stripping of the Great Saphenous Vein: 5 year Results of a Randomized Clinical Trial (RELACS Study)

K. Rass, N. Fringse, P. Glowacki, S. Gräber, W. Tilgen, T. Vogt

Objective: To compare the long-term clinical efficacy of endovenous laser ablation (EVLA) with high ligation and stripping (HLS) as standard treatment for great saphenous vein (GSV) incompetence.

01 octubre 2015

EUROPEAN JOURNAL OF VASCULAR & ENDOVASCULAR SURGERY. Short-Term Clinical Experience with a Dedicated Venous Nitinol Stent: Initial Results with the Sinus-Venous Stent

M.A.F. de Wolf, R. de Graaf, R.L.M. Kurstjens, S. Penninx, H. Jalaie, C.H.A. Wittens DOI: http://dx.doi.org/10.1016/j.ejvs.2015.05.011

Objective: Deep venous stenting has become the primary treatment option for chronic venous obstructive disease, both for iliac vein compression and post-thrombotic venous lesions. Until recently, only stents aimed at arterial pathology were used, because no dedicated venous stents were available. However, three such stents have now become available. These venous stents are characterized by increased length, diameter, flexibility, and radial force. This study reports an early experience with one of these devices; the sinus Venous stent (OptiMed GmbH, Ettlingen, Germany).

01 octubre 2015

JOURNAL OF VASCULAR SURGERY. Role of coexisting contralateral primary venous disease in development of post-thrombotic syndrome following catheter-based treatment of iliofemoral deep venous thrombosis

John J. Lee, MD, Mustafa Al-Jubouri, MD, Robin Acino, MPH, Anthony J. Comerota, MD, FACS, FACC, Fedor Lurie, MD, PhD

Background: It has been reported that early clot removal benefits patients with iliofemoral deep venous thrombosis (DVT) by removing obstruction and preserving valve function. However, a substantial number of patients who had successful clot removal develop post-thrombotic syndrome (PTS). Residual thrombus and rethrombosis play a part in this phenomenon, but the role of coexisting primary chronic venous disease (PCVD) in these patients has not been studied.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.